People

Peter Vanderklish

Peter Vanderklish is Spinogenix’s chief science officer. His research concerns synaptic plasticity, dendritic spines and the molecular mechanisms of neurological conditions, including Fragile X syndrome. His graduate training was at UC Irvine.